412260006: Olmesartan medoxomil (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\Substance with renin-angiotensin system inhibitor mechanism of action (substance)\Angiotensin II receptor antagonist\Olmesartan medoxomil (substance)
\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Antihormone\Angiotensin II receptor antagonist\Olmesartan medoxomil (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Azole\...

\Tetrazole (substance)\Olmesartan medoxomil (substance)

\Imidazole\Olmesartan medoxomil (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Azole\Tetrazole (substance)\Olmesartan medoxomil (substance)
\Organic compound\Organic cyclic compound\Heterocyclic compound\Azole\Imidazole\Olmesartan medoxomil (substance)
\Organic compound\Organic nitrogen compound\Azole\Tetrazole (substance)\Olmesartan medoxomil (substance)
\Organic compound\Organic nitrogen compound\Azole\Imidazole\Olmesartan medoxomil (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Olmesartan medoxomil (substance)	Is a	Olmesartan (substance)	false	Inferred relationship	Some
Olmesartan medoxomil (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Angiotensin II receptor antagonist (disposition)	true	Inferred relationship	Some
Olmesartan medoxomil (substance)	Is a	Angiotensin II receptor antagonist	true	Inferred relationship	Some
Olmesartan medoxomil (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Olmesartan (substance)	true	Inferred relationship	Some
Olmesartan medoxomil (substance)	Is a	Tetrazole (substance)	true	Inferred relationship	Some
Olmesartan medoxomil (substance)	Is a	Imidazole	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Olmesartin medoxomil + hydrochlorothiazide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Olmesartan medoxomil 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
olmésartan médoxomil	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Olmesartan medoxomil 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Olmesartan medoxomil 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Olmesartan medoxomil 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Product containing amlodipine and olmesartan (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
médicament contenant olmésartan médoxomil et hydrochlorothiazide	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Product containing amlodipine and hydrochlorothiazide and olmesartan medoxomil	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some
Olmesartan medoxomil 5 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Olmesartan medoxomil 5 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Olmesartan medoxomil 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Olmesartan medoxomil 20 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Olmesartan medoxomil 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Olmesartan medoxomil 40 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Olmesartan medoxomil 10 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Olmesartan medoxomil 10 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Product containing precisely amlodipine besilate 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Olmesartan medoxomil 20 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Olmesartan medoxomil 5 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Olmesartan medoxomil 40 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Olmesartan medoxomil 10 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	1
Amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	3
Amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	3
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	3
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	3
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	3
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	3
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	3
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg and olmesartan medoxomil 40 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	3
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	3
Amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	3
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 20 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Hydrochlorothiazide 12.5 mg and olmesartan medoxomil 40 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Amlodipine (as amlodipine besilate) 5 mg and olmesartan medoxomil 20 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and olmesartan medoxomil 40 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Chlortalidone 12.5 mg and olmesartan medoxomil 40 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Chlortalidone 12.5 mg and olmesartan medoxomil 40 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Product containing chlortalidone and olmesartan medoxomil in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Product containing only chlortalidone and olmesartan medoxomil (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Product containing chlortalidone and olmesartan medoxomil (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Product containing only chlortalidone and olmesartan medoxomil in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Product containing only cilnidipine and olmesartan medoxomil (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Product containing cilnidipine and olmesartan medoxomil (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Product containing only cilnidipine and olmesartan medoxomil in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Product containing cilnidipine and olmesartan medoxomil in oral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Cilnidipine 10 mg and olmesartan medoxomil 20 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Cilnidipine 10 mg and olmesartan medoxomil 20 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	2
Product containing precisely hydrochlorothiazide 25 milligram and olmesartan medoxomil 20 milligram/1 each conventional release oral tablet (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Olmesartan medoxomil (substance)	Inferred relationship	Some	2

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2467712014	Olmesartan medoxomil (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2473849010	Olmesartan medoxomil	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
370661000195117	olmesartan medoxomil	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
829291000172110	olmésartan médoxomil	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
3335431001000118	Olmesartanmedoxomil	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
3335441001000113	Olmesartan medoxomil	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module